Cargando…

In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China

Acinetobacter baumannii has emerged globally as a difficult-to-treat nosocomial pathogen and become resistant to carbapenems, resulting in limited treatment options. KBP-7072 is a novel semisynthetic aminomethylcycline, expanded spectrum tetracycline antibacterial agent with completed phase 1 clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Renru, Ding, Li, Yang, Yang, Guo, Yan, Yin, Dandan, Wu, Shi, Zhi, Peiyuan, Zhu, Demei, Liu, Qingmei, Tan, Xiaojuan, Zhu, Yuanju, Zhang, Jay, Li, Li, Hu, Fupin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826824/ https://www.ncbi.nlm.nih.gov/pubmed/35138143 http://dx.doi.org/10.1128/spectrum.01471-21

Ejemplares similares

Nonclinical Pharmacokinetics, Protein Binding, and Elimination of KBP-7072, an Aminomethylcycline Antibiotic, in Animal Models
por: Tan, Xiaojuan, et al.
Publicado: (2020)

Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019
por: Huband, Michael D., et al.
Publicado: (2022)

In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms
por: Pfaller, Michael A, et al.
Publicado: (2021)

1389. Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model Against S. aureus (SA) and S. pneumoniae (SPN)
por: Lepak, Alexander J, et al.
Publicado: (2018)

Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii
por: Wang, Leilei, et al.
Publicado: (2021)

Performance of Ceftazidime-Avibactam 30/20-μg and 10/4-μg Disks for Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa
por: Han, Renru, et al.
Publicado: (2023)

Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates
por: Han, Renru, et al.
Publicado: (2022)

Comparison of Four Carbapenemase Detection Methods for bla(KPC-2) Variants
por: Ding, Li, et al.
Publicado: (2021)

In Vitro Activity of MRX-8 and Comparators Against Clinical Isolated Gram-Negative Bacilli in China
por: Wu, Shi, et al.
Publicado: (2022)

Pharmacokinetics and Drug–Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo
por: Wang, Ping, et al.
Publicado: (2023)

Activities of Eravacycline, Tedizolid, Norvancomycin, Nemonoxacin, Ceftaroline, and Comparators against 1,871 Staphylococcus and 1,068 Enterococcus Species Isolates from China: Updated Report of the CHINET Study 2019
por: Ding, Li, et al.
Publicado: (2022)

In Vitro Activity of New β-Lactam–β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019
por: Guo, Yan, et al.
Publicado: (2022)

Antimicrobial activity of ceftobiprole and comparator agents when tested against gram-positive and -negative organisms collected across China (2016–2018)
por: Dandan, Yin, et al.
Publicado: (2022)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

697. Evaluation of Contezolid Activity to Anaerobic and Gram-positive-cocci Isolates from a Phase 3 Acute Bacterial Skin and Skin Structure Infection Clinical Trial (MRX-I-06)
por: Yang, Yang, et al.
Publicado: (2019)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
por: Kuo, Shu-Chen, et al.
Publicado: (2015)

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae
por: Ding, Li, et al.
Publicado: (2022)

Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
por: Hua, Yunfen, et al.
Publicado: (2018)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

2478. Surveillance of antibacterial resistance among clinical isolates from hospitals in Shanghai: results of 2018
por: Yang, Yang, et al.
Publicado: (2019)

First Report of bla(OXA-677) with Enhanced Meropenem-Hydrolyzing Ability in Pseudomonas aeruginosa in China
por: Sun, Yue, et al.
Publicado: (2021)

Characterization of the First Carbapenem-Resistant Pseudocitrobacter faecalis Harboring bla(OXA-181) in China
por: Shi, Qingyu, et al.
Publicado: (2022)

Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation
por: Yang, Cheng-Hong, et al.
Publicado: (2019)

Acinetobacter Baumannii Phages: Past, Present and Future
por: Tu, Qihang, et al.
Publicado: (2023)

Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India
por: Vijayakumar, Saranya, et al.
Publicado: (2019)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam
por: Shen, Siquan, et al.
Publicado: (2022)

The Acinetobacter baumannii group: a systemic review
por: Zhang, Hua-zhong, et al.
Publicado: (2013)

Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis
por: Huang, Zhenhua, et al.
Publicado: (2015)

CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI
por: Wang, Yuhang, et al.
Publicado: (2022)

In vitro Activity of Lefamulin Against the Common Respiratory Pathogens Isolated From Mainland China During 2017–2019
por: Wu, Shi, et al.
Publicado: (2020)

Multiple Novel Ceftazidime-Avibactam-Resistant Variants of bla(KPC-2)-Positive Klebsiella pneumoniae in Two Patients
por: Shi, Qingyu, et al.
Publicado: (2022)

Mutation of CarO participates in drug resistance in imipenem‐resistant Acinetobacter baumannii
por: Zhu, Li‐Jing, et al.
Publicado: (2019)

Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
por: Li, Henan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5ebs8kig58egsf6imhu0mfmg2